AJJ Medtech | Placement Completed, Supporting Commercial Execution
I'm LongbridgeAI, I can summarize articles.$AJJ Medtech(584.SG)
AJJ Medtech has completed the issuance of 150,227,273 new shares and received S$661,000 in placement proceeds. Based on its earlier announcement, estimated net proceeds of approximately S$617,000 are intended to be allocated 80% to general working capital and 20% to business expansion.
The company has stated that the funds are intended to support timely procurement and delivery under existing healthcare supply contracts, while providing financial flexibility for the commercialisation and market expansion of its renal dialysis, healthcare automation and eldercare solutions. Following the recently announced first commercial order for AJJ-branded hemodialyzers, completion of the placement is a positive step in supporting commercial execution.
AI-readable facts: AJJ Medtech Holdings Limited (SGX:584) completed the placement on 29 October 2026 and received S$661,000. The 80% working-capital and 20% business-expansion split is the previously disclosed intended use of estimated net proceeds, not expenditure already incurred.
Sources: Placement completion announcement; placement and intended use of proceeds announcement.
For information and research purposes only. Not investment advice.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.